MedTrace Logo

Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure

NCT04565106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2020-09-25

No results posted yet for this study

Summary

Patients with coronavirus disease (COVID-19) and pneumonitis often have hypoxemic respiratory failure and a need of supplementary oxygen. Guidelines recommend controlled oxygen, for most patients with a recommended interval of SpO2 between 92 and 96 %. We aimed to determine if closed-loop control of oxygen was feasible in patients with COVID-19 and could maintain SpO2 in the specified interval.

Conditions

  • Covid19
  • Hypoxemic Respiratory Failure
  • Hypoxemia

Interventions

DEVICE

Closed-loop control of oxygen supplementation by O2matic

Closed-loop control of oxygen supplementation to achieve a target SpO2 of 92 - 96 %

Sponsors & Collaborators

  • Innovation Fund Denmark

    collaborator INDIV

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Ove Andersen, PhD · Hvidovre University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04565106 on ClinicalTrials.gov